Latest Market Strategy News

Page 4 of 33
Fortuna Metals has appointed mineral sands marketing veteran Ian Hind to lead its marketing strategy as it ramps up drilling at the Mkanda and Kampini rutile projects in Malawi, aiming to advance resource definition and commercial viability in 2026.
Maxwell Dee
Maxwell Dee
7 May 2026
Magellan Financial Group is handing over management of its $5.3 billion global equities funds to Vinva, adopting a new systematic strategy and slashing fees to boost client value.
Claire Turing
Claire Turing
5 May 2026
Gentrack Group trims its FY26 revenue outlook amid strategic investments and signals a $20 million on-market share buyback post-H1 results.
Sophie Babbage
Sophie Babbage
5 May 2026
Pure Resources has partnered with Oak Ridge National Laboratory to develop a rare earth extraction process from its Garnet Hills garnet, aiming to add critical minerals value alongside its industrial minerals business.
Maxwell Dee
Maxwell Dee
1 May 2026
Astron Limited has updated its Donald Rare Earth and Mineral Sands Project with a refreshed Bankable Feasibility Study showing a pre-tax NPV8 of AUD 759 million, strengthened Indigenous agreements, and a targeted Final Investment Decision in Q2 2026.
Maxwell Dee
Maxwell Dee
30 Apr 2026
One Click Group delivered a remarkable 1000% increase in new users and a 64% reduction in acquisition costs in Q1 2026, setting the stage for strong revenue growth ahead of tax season.
Victor Sage
Victor Sage
30 Apr 2026
Bannerman Energy has locked in a landmark US$321.5 million strategic investment from CNNC Overseas Limited, enabling debt-free construction of its Etango Uranium Project and setting the stage for a Final Investment Decision in H2 2026.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.
Ada Torres
Ada Torres
29 Apr 2026
Acrux pivots from generics to developing a Female Testosterone therapy for HSDD, leveraging FDA feedback and a strong US market opportunity.
Ada Torres
Ada Torres
28 Apr 2026
CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.
Ada Torres
Ada Torres
28 Apr 2026
American Tungsten & Antimony (ASX: AT4) has set up a Level 1 ADR program with Deutsche Bank, paving the way for its planned Nasdaq listing in Q2 2026 and opening U.S. dollar trading access for American investors.
Maxwell Dee
Maxwell Dee
28 Apr 2026
IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.
Maxwell Dee
Maxwell Dee
27 Apr 2026

Browse the archive

Full archive